Market Size –
The acute migraine treatment market size has grown rapidly in recent years. It will grow from $2.35 billion in 2023 to $2.60 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to the increasing prevalence of migraine, growth of specialty clinics, increasing funding for migraine research, growth in clinical trials, and increasing use of preventive medications.
The acute migraine treatment market size is expected to see rapid growth in the next few years. It will grow to $4.00 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to the increasing prevalence of migraine, growing investment in migraine research, rising demand for non-invasive treatment options, rising demand for quick-acting relief options, and growing emphasis on patient-centric drug development. Major trends in the forecast period include technological advancements, the adoption of neuromodulation devices, personalized medicine, telemedicine, and diagnostic tools.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/acute-migraine-treatment-global-market-report
Scope Of Acute Migraine Treatment Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Acute Migraine Treatment Market Overview
Market Drivers –
The surging work pressure is expected to propel the growth of the acute migraine treatment market going forward. Work pressure refers to the mental, emotional, and physical strain experienced by employees due to the demands and challenges of their job responsibilities. Factors leading to a surge in work pressure include tight deadlines, a lack of resources and support, poor work-life balance, unclear roles and responsibilities, interpersonal conflicts, and organizational changes. Acute migraine treatment for surging work pressure involves managing the symptoms of migraines that may be triggered or exacerbated by high-stress situations, such as a demanding work environment. For instance, in 2023, according to Mental Health America, a US-based community-based organization, around 81% of workers reported that workplace stress affected their mental health, compared to 78% of respondents in 2021. Therefore, the surging work pressure is driving the acute migraine treatment market.
Market Trends –
Major companies operating in the acute migraine treatment market are focused on developing innovative products, such as migraine nasal sprays, to enhance the efficacy and convenience of migraine relief. Migraine nasal sprays are a form of acute migraine treatment that delivers medication through the nasal passages. This route of administration can be advantageous because it allows for rapid absorption of the medication, which can provide faster relief compared to oral medications. For instance, in March 2023, Pfizer Inc., a US-based biotechnology company, launched ZAVZPRET (zavegepant) Migraine Nasal Spray, approved by the Food and Drug Administration (FDA), a US-based federal agency. This innovative nasal spray leverages the efficacy of zavegepant, a CGRP receptor antagonist, which blocks the calcitonin gene-related peptide (CGRP) pathway to provide rapid and targeted relief from migraine attacks. The unique features of ZAVZPRET include its fast-acting formulation, which delivers relief within 15 minutes, making it a convenient option for individuals seeking quick alleviation from severe migraine symptoms.
The acute migraine treatment market covered in this report is segmented –
1) By Drug Type: Triptans, Calcitonin Gene-Related Peptide Antagonist, Nonsteroidal Anti-Inflammatory Drugs, Beta-Adrenergic, Ergot Alkaloids, Other Drug Types
2) By Route Of Administration: Oral, Injection, Other Routes Of Administration
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, E-Commerce
Get an inside scoop of the acute migraine treatment market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18208&type=smp
Regional Insights –
North America was the largest region in the acute migraine treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute migraine treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the acute migraine treatment market are Pfizer Inc., Johnson And Johnson, Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Viatris Inc., Allergan plc, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Endo International plc, Supernus Pharmaceuticals Inc., Collegium Pharmaceutical Inc., Upsher-Smith Laboratories LLC, BioDelivery Sciences International Inc., Axsome Therapeutics Inc., Impel NeuroPharma Inc., Currax Pharmaceuticals LLC, Satsuma Pharmaceuticals Inc.
Table of Contents
1. Executive Summary
2. Acute Migraine Treatment Market Report Structure
3. Acute Migraine Treatment Market Trends And Strategies
4. Acute Migraine Treatment Market – Macro Economic Scenario
5. Acute Migraine Treatment Market Size And Growth
…..
27. Acute Migraine Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
